NCT00177827View on ClinicalTrials.gov

Voriconazole Prophylaxis Against Aspergillosis in Lung Transplant Recipients

CompletedOBSERVATIONAL
Enrollment

104

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

March 31, 2006

Conditions
Post Lung Transplantation
Trial Locations (1)

15213

University of Pittsburgh Medical Center, Pittsburgh

All Listed Sponsors
collaborator

National Center for Research Resources (NCRR)

NIH

lead

University of Pittsburgh

OTHER

NCT00177827 - Voriconazole Prophylaxis Against Aspergillosis in Lung Transplant Recipients | Biotech Hunter | Biotech Hunter